-
Add to Cart The item has been addedS651389-50mg(Rac)-SNC80 is a racemate of SNC80 ( HY-101202 ). SNC80 (NIH 10815) is a potent, highly selective and non-peptide δ-opioid receptor agonist with a K i of 1.78 nM and an IC 50 of 2.73 nM. SNC80 shows antinociceptive, antihyperalgesic and -
Add to Cart The item has been addedS651389-5mg(Rac)-SNC80 is a racemate of SNC80 ( HY-101202 ). SNC80 (NIH 10815) is a potent, highly selective and non-peptide δ-opioid receptor agonist with a K i of 1.78 nM and an IC 50 of 2.73 nM. SNC80 shows antinociceptive, antihyperalgesic and -
Add to Cart The item has been addedS651962-100mg(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid.In Vitro(Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion -
Add to Cart The item has been addedS651962-10mg(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid.In Vitro(Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion -
Add to Cart The item has been addedS651962-25mg(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid.In Vitro(Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion -
Add to Cart The item has been addedS651962-50mg(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid.In Vitro(Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion -
Add to Cart The item has been addedS651962-5mg(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid.In Vitro(Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion -
Add to Cart The item has been addedS656898-1ml(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid.In Vitro(Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion -
Add to Cart The item has been addedT651255-100mg(Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, -
Add to Cart The item has been addedT651255-10mg(Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, -
Add to Cart The item has been addedT651255-50mg(Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, -
Add to Cart The item has been addedT651255-5mg(Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP,
